Back to the main directory
Press Release
- Wesdome Expands Recently Discovered Hanging and Footwall Zones and Extends Kiena Deep A Zone Over 125 Metres Down Plunge by GlobeNewsWire
- OTC Markets Group Welcomes FFBW, Inc. to OTCQX by GlobeNewsWire
- Latham Group, Inc. Announces Fourth Quarter and Full Year Fiscal 2022 Earnings Release and Conference Call Date by GlobeNewsWire
- Boralex : déclaration de dividende by GlobeNewsWire
- Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results by GlobeNewsWire
- Breckenridge Distillery Strikes Gold at 2023 World Whiskies Awards by GlobeNewsWire
- Amicus Therapeutics to Announce Full-Year 2022 Financial Results on March 1, 2023 by GlobeNewsWire
- POET Technologies to Demonstrate 800G Optical Engines and Light Source Products at OFC 2023 by GlobeNewsWire
- Purple Biotech Announces First Patient Dosed in Open Label, Randomized Part of CM24 Phase 2 Clinical Trial by GlobeNewsWire
- GlobalFoundries Reports Fourth Quarter and Fiscal Year 2022 Financial Results by GlobeNewsWire
- Novel Approach to Treating Advanced Liver Cancer with Namodenoson Published in Leading Scientific Journal: 12-Month Survival of 44% for Namodenoson vs. 18% for Placebo by BusinessWire
- Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s) by EQS Group AG
- Indkaldelse til ordinær generalforsamling by GlobeNewsWire
- Sensei Biotherapeutics to Present New Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Keystone Symposia on Next Generation Antibody Therapeutics by GlobeNewsWire
- FTI Consulting 2023 Global CFO Survey: CFOs Expect Slower Growth into 2024 Due to Inflation, Rising Costs by GlobeNewsWire
- Visa and Tingo Mobile, an MICT subsidiary, Launch Partnership to Promote Financial Inclusion and Expand Access to Digital Payment Channels Across Africa by GlobeNewsWire
- Bombardier annonce un avis de rachat partiel visant ses billets de premier rang 7,50 % échéant en 2025 d’un capital de 500 000 000 $ by GlobeNewsWire
- TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (ublituximab) in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum by GlobeNewsWire
- Quipt Home Medical Reports Record First Quarter Fiscal 2023 Financial Results Posting Positive Net Income, Revenue Growth of 38% and Adjusted EBITDA Growth of 50% by GlobeNewsWire
- Parsons Space Operations Center Unifies Government and Commercial Technologies to Respond to Critical Space Demands by GlobeNewsWire
- Turkiye Garanti Bankasi A.S.: Coupon Rate of Subordinated Debt Securities to Qualified Investors by EQS Group AG
- Alliance Trust PLC - Net Asset Value by GlobeNewsWire
- OK Prepares to Deploy More Than 300 Tritium DC Fast Chargers to Expand Denmark’s EV Infrastructure by GlobeNewsWire
- Taboola to Release Fourth Quarter 2022 Financial Results and Host Earnings Conference Call on February 24, 2023 and Provide Details on the March 1, 2023 Yahoo Information Session by GlobeNewsWire
- Middlefield Banc Corp. Announces 2023 First-Quarter Cash Dividend Payment by GlobeNewsWire